Cited by 853Health Systems, Economic Evaluations, Quality of LifePharmaceutical Economics and PolicyGlobal Health Care Issues

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Thresholds for the cost–effectiveness of interventions: alternative approaches

Open access

Marseille, Elliot, Larson, Bruce, Kazi, Dhruv S, Kahn, James G, Rosen, Sydney·2015·Bulletin of the World Health Organization

DOI 10.2471/blt.14.138206PMC PMC4339959

Open this paper in CoChat — free account

Abstract

Many countries use the cost-effectiveness thresholds recommended by the World Health Organization's Choosing Interventions that are Cost-Effective project (WHO-CHOICE) when evaluating health interventions. This project sets the threshold for cost-effectiveness as the cost of the intervention per disability-adjusted life-year (DALY) averted less than three times the country's annual gross domestic product (GDP) per capita. Highly cost-effective interventions are defined as meeting a threshold per DALY averted of once the annual GDP per capita. We argue that reliance on these thresholds reduces the value of cost-effectiveness analyses and makes such analyses too blunt to be useful for most decision-making in the field of public health. Use of these thresholds has little theoretical justification, skirts the difficult but necessary ranking of the relative values of locally-applicable interventions and omits any consideration of what is truly affordable. The WHO-CHOICE thresholds set such a low bar for cost-effectiveness that very few interventions with evidence of efficacy can be ruled out. The thresholds have little value in assessing the trade-offs that decision-makers must confront. We present alternative approaches for applying cost-effectiveness criteria to choices in the allocation of health-care resources.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.2471/blt.14.138206

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
The World Health Report 2002 - Reducing Risks, Promoting Healthy Life
Available, N. A. N. (2003) · Education for Health · doi:10.1080/1357628031000116808 · Cited by 6,078
Methods for the economic evaluation of health care programmes
Wilson, S. (1987) · Journal of Epidemiology & Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,312
Cost-Benefit Analysis: Concepts and Practice
Boardman, A. E., Greenberg, D. H., Vining, A. R., & Weimer, D. L. (1996) · Cited by 1,920
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., Loder, E., et al. (2013) · BMJ · doi:10.1136/bmj.f1049 · Cited by 1,776
Methods for the economic evaluation of health care programmes, 3rd ed
Adamiak, G. T. (2006) · PubMed Central · Cited by 953
The Value of Life and the Rise in Health Spending
Hall, R. E., & Jones, C. I. (2007) · The Quarterly Journal of Economics · doi:10.1162/qjec.122.1.39 · Cited by 924
Willingness to Pay for a Quality-adjusted Life Year: In Search of a Standard
Hirth, R. A., Chernew, M. E., Miller, E., Fendrick, A. M., & Weissert, W. G. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000310 · Cited by 850
Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?
Thorlund, K., Devereaux, P. J., Wetterslev, J., Guyatt, G. H., Ioannidis, J. P. A., Thabane, L., Gluud, L. L., Als-Nielsen, B. E. T., & Gluud, C. N. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn179 · Cited by 834
Cost-effectiveness analysis.
Robinson, R. (1993) · BMJ · doi:10.1136/bmj.307.6907.793 · Cited by 819

Flagged first, then by citations

Show all 42 references

Sorted by citations

European guidance for the diagnosis and management of osteoporosis in postmenopausal women
on behalf of the Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF), Kanis, J. A., Cooper, C., Rizzoli, R., & Reginster, J.-Y. (2019) · Osteoporosis International · doi:10.1007/s00198-018-4704-5 · Cited by 1,900
Cost–effectiveness thresholds: pros and cons
Bertram, M., Lauer, J. A., de Joncheere, K., Edejer, T. T.-T., Hutubessy, R. C. W., Kiény, M.-P., & Hill, S. R. (2016) · Bulletin of the World Health Organization · doi:10.2471/blt.15.164418 · Cited by 789
A guide to aid the selection of diagnostic tests
Kosack, C., Page, A., & Klatser, P. R. (2017) · Bulletin of the World Health Organization · doi:10.2471/blt.16.187468 · Cited by 417
On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review
Cameron, D. A., Ubels, J., & Norström, F. (2018) · Global Health Action · doi:10.1080/16549716.2018.1447828 · Cited by 383
Vaccine impact: Benefits for human health
Doherty, M. T., Buchy, P., Standaert, B. A., Giaquinto, C., & Prado-Cohrs, D. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.10.025 · Cited by 291
Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures
Pichón-Rivière, A., Drummond, M., Palacios, A., Martí, S. G., & Augustovski, F. (2023) · The Lancet Global Health · doi:10.1016/s2214-109x(23)00162-6 · Cited by 280
Point of Care Diagnostics in Resource-Limited Settings: A Review of the Present and Future of PoC in Its Most Needed Environment
Heidt, B., Siqueira, W. F., Eersels, K., Diliën, H., van Grinsven, B., Fujiwara, R. T., & Cleij, T. J. (2020) · Biosensors · doi:10.3390/bios10100133 · Cited by 293
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
Turner, H. C., Archer, R. A., Downey, L. E., Isaranuwatchai, W., Chalkidou, K., Jit, M., & Teerawattananon, Y. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.722927 · Cited by 224
Exposure-based assessment and economic valuation of adverse birth outcomes and cancer risk due to nitrate in United States drinking water.
Temkin, A. M., Evans, S., Manidis, T. D., Campbell, C., & Naidenko, O. V. (2019) · Environmental Research · doi:10.1016/j.envres.2019.04.009 · Cited by 229
Cost-Effectiveness Thresholds: the Past, the Present and the Future
Thokala, P., Ochalek, J., Leech, A. A., & Tong, T. (2018) · PharmacoEconomics · doi:10.1007/s40273-017-0606-1 · Cited by 212
Managed retreat as a strategy for climate change adaptation in small communities: public health implications
Dannenberg, A. L., Frumkin, H., Hess, J. J., & Ebi, K. L. (2019) · Climatic Change · doi:10.1007/s10584-019-02382-0 · Cited by 169
Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies
Leech, A. A., Kim, D. D., Cohen, J. T., & Neumann, P. J. (2018) · Value in Health · doi:10.1016/j.jval.2017.12.016 · Cited by 174
Health impact and related cost of ambient air pollution in Tehran
Bayat, R., Ashrafi, K., Motlagh, M. S., Hassanvand, M. S., Daroudi, R., Fink, G., & Künzli, N. (2019) · Environmental Research · doi:10.1016/j.envres.2019.108547 · Cited by 171
Understanding the global measurement of willingness to pay in health
McDougall, J. A., Furnback, W. E., Wang, B. C. M., & Mahlich, J. (2020) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2020.1717030 · Cited by 167
Transient elastography for screening of liver fibrosis: cost-effectiveness analysis from six prospective cohorts in Europe and Asia
Serra-Burriel, M., Graupera, I., Torán, P., Thiele, M., Roulot, D., Wai-Sun Wong, V., Neil Guha, I., Fabrellas, N., Arslanow, A., Expósito, C., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.08.019 · Cited by 160
Methods for the Economic Evaluation of Health Care Interventions for Priority Setting in the Health System: An Update From WHO CHOICE
Bertram, M. Y., Lauer, J. A., Stenberg, K., & Edejer, T. T. T. (2021) · International Journal of Health Policy and Management · doi:10.34172/ijhpm.2020.244 · Cited by 160
Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
Godman, B., Bucsics, A., Bonanno, P. V., Oortwijn, W., Rothe, C. C., Ferrario, A., Bosselli, S., Hill, A., Martin, A., Simoens, S., et al. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00328 · Cited by 140
Cost Effectiveness of Gastric Cancer Screening According to Race and Ethnicity
Saumoy, M., Schneider, Y., Shen, N. T., Kahaleh, M., Sharaiha, R. Z., & Shah, S. C. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.026 · Cited by 161
Cost-effectiveness of Artificial Intelligence as a Decision-Support System Applied to the Detection and Grading of Melanoma, Dental Caries, and Diabetic Retinopathy
Gomez Rossi, J., Rojas-Perilla, N., Krois, J., & Schwendicke, F. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0269 · Cited by 141
The use of cost-effectiveness thresholds for evaluating health interventions in low- and middle-income countries from 2015 to 2020: a review
Kazibwe, J., Gheorghe, A., Wilson, D., Ruiz, F., Chalkidou, K., & Chi, Y.-L. (2022) · Value in Health · doi:10.1016/j.jval.2021.08.014 · Cited by 139
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report
Mauskopf, J., Standaert, B. A., Connolly, M. P., Culyer, A. J., Garrison, L. P., Hutubessy, R. C. W., Jit, M., Pitman, R., Revill, P. A., & Severens, J. L. (2018) · Value in Health · doi:10.1016/j.jval.2018.08.005 · Cited by 131
Cost-effectiveness thresholds in health care: a bookshelf guide to their meaning and use
Culyer, A. J. (2016) · Health Economics Policy and Law · doi:10.1017/s1744133116000049 · Cited by 128
Cost effectiveness of a government supported policy strategy to decrease sodium intake: global analysis across 183 nations
Webb, M., Fahimi, S., Singh, G. M., Khatibzadeh, S., Micha, R., Powles, J. W., & Mozaffarian, D. (2017) · BMJ · doi:10.1136/bmj.i6699 · Cited by 128
Cost-effectiveness of Osimertinib in the First-Line Treatment of Patients With EGFR-Mutated Advanced Non–Small Cell Lung Cancer
Aguiar, P. N., Haaland, B., Park, W., San Tan, P., del Giglio, A., & de Lima Lopes, G. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1395 · Cited by 124
Beyond ratios - flexible and resilient nurse staffing options to deliver cost-effective hospital care and address staff shortages: A simulation and economic modelling study
Griffiths, P., Saville, C. E., Ball, J., Jones, J., & Monks, T. (2021) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2021.103901 · Cited by 120
Estimating a cost-effectiveness threshold for health care decision-making in South Africa
Edoka, I., & Stacey, N. (2019) · Health Policy and Planning · doi:10.1093/heapol/czz152 · Cited by 119
An International Analysis of Dialysis Services Reimbursement
van der Tol, A., Lameire, N. H., Morton, R. L., Biesen, W. V., & Vanholder, R. C. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08150718 · Cited by 118
Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
Su, S., Wong, W. C. W., Zou, Z., Cheng, D. D., Ong, J. J., Chan, P., Ji, F., Yuen, M., Zhuang, G., Seto, W., et al. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00517-9 · Cited by 118
A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease
Pillai, N., Dusheiko, M., Burnand, B., & Pittet, V. E. H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185500 · Cited by 111
Cost-Effectiveness of Immune Checkpoint Inhibition inBRAFWild-Type Advanced Melanoma
Kohn, C. G., Zeichner, S. B., Chen, Q., Montero, A. J., Goldstein, D. A., & Flowers, C. R. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6336 · Cited by 110
Cost-effectiveness of community-based screening and treatment for chronic hepatitis B in The Gambia: an economic modelling analysis
Nayagam, S., Conteh, L., Sicuri, E., Shimakawa, Y., Suso, P., Tamba, S., Njie, R., Njai, H. F., Lemoine, M., Hallett, T. B., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30101-2 · Cited by 105
Cost of New Technologies in Prostate Cancer Treatment: Systematic Review of Costs and Cost Effectiveness of Robotic-assisted Laparoscopic Prostatectomy, Intensity-modulated Radiotherapy, and Proton Beam Therapy
Schroeck, F. R., Jacobs, B. L., Bhayani, S. B., Nguyen, P. L., Penson, D. F., & Hu, J. C. (2017) · European Urology · doi:10.1016/j.eururo.2017.03.028 · Cited by 108
¿Qué es una intervención sanitaria eficiente en España en 2020?
Sacristán, J. A., Oliva, J., Campillo-Artero, C., Puig‐Junoy, J., Prades, J. L. P., Dilla, T., Rubio‐Terres, C., & Rubio, V. O. (2019) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2019.06.007 · Cited by 107
Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life
Cai, D., Shi, S., Jiang, S., Si, L., Wu, J. H., & Jiang, Y. (2021) · The European Journal of Health Economics · doi:10.1007/s10198-021-01384-z · Cited by 98
Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models
Menzies, N. A., Gomez, G. B., Bozzani, F. M., Chatterjee, S., Foster, N., Baena, I. G., Laurence, Y. V., Sun, Q., Siroka, A. M., Sweeney, S., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30265-0 · Cited by 92
Using Economic Evidence to Set Healthcare Priorities in Low‐Income and Lower‐Middle‐Income Countries: A Systematic Review of Methodological Frameworks
Wiseman, V. L., Mitton, C., Doyle‐Waters, M. M., Drake, T., Conteh, L., Newall, A. T., Onwujekwe, O. E., & Jan, S. (2016) · Health Economics · doi:10.1002/hec.3299 · Cited by 86
Cost effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpura
Goshua, G., Sinha, P., Hendrickson, J. E., Tormey, C. A., Bendapudi, P. K., & Lee, A. I. (2020) · Blood · doi:10.1182/blood.2020006052 · Cited by 85
Affordable Robotics for Upper Limb Stroke Rehabilitation in Developing Countries: A Systematic Review
Demofonti, A., Carpino, G., Zollo, L., & Johnson, M. J. (2021) · IEEE Transactions on Medical Robotics and Bionics · doi:10.1109/tmrb.2021.3054462 · Cited by 85
Systematic review of cost-effectiveness studies of human papillomavirus (HPV) vaccination: 9-Valent vaccine, gender-neutral and multiple age cohort vaccination
Ng, S. S., Hutubessy, R. C. W., & Chaiyakunapruk, N. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.024 · Cited by 83
The Productivity Burden of Diabetes at a Population Level
Magliano, D. J., Martin, V. J., Owen, A. J., Zomer, E., & Liew, D. (2018) · Diabetes Care · doi:10.2337/dc17-2138 · Cited by 83
Costs and cost-effectiveness of improved nurse staffing levels and skill mix in acute hospitals: A systematic review
Griffiths, P., Saville, C. E., Ball, J., Dall’Ora, C., Meredith, P., Turner, L., & Jones, J. (2023) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2023.104601 · Cited by 82
Next-generation multiple myeloma treatment: a pharmacoeconomic perspective
Rajkumar, S. V., & Harousseau, J. L. (2016) · Blood · doi:10.1182/blood-2016-09-692947 · Cited by 80
Value and Cost of Myeloma Therapy
Rajkumar, S. V. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200867 · Cited by 77
Economic assessment of neonatal intensive care
Cheah, I. G. S. (2019) · Translational Pediatrics · doi:10.21037/tp.2019.07.03 · Cited by 80
What next after GDP-based cost-effectiveness thresholds?
Chi, Y.-L., Blecher, M., Chalkidou, K., Culyer, A. J., Claxton, K., Edoka, I., Glassman, A. L., Kreif, N., Jones, I., Mirelman, A. J., et al. (2020) · Gates Open Research · doi:10.12688/gatesopenres.13201.1 · Cited by 78
Sustainability and affordability of cancer drugs: a novel pricing model
Groot, C. A. U., & Löwenberg, B. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0027-x · Cited by 77
The pitfalls of scaling up evidence-based interventions in health
Zomahoun, H. T. V., Charif, A. B., Freitas, A., Garvelink, M. M., Menear, M., Dugas, M., Adekpedjou, R., & Légaré, F. (2019) · Global Health Action · doi:10.1080/16549716.2019.1670449 · Cited by 81
The cost-effectiveness of hypertension management in low-income and middle-income countries: a review
Kostova, D., Spencer, G., Moran, A. E., Cobb, L. K., Husain, M., Datta, B., Matsushita, K., & Nugent, R. (2020) · BMJ Global Health · doi:10.1136/bmjgh-2019-002213 · Cited by 75
Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis
Virelli, C. R., Mohiuddin, A. G., & Kennedy, J. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01600-7 · Cited by 81
Clinical Impact and Cost-effectiveness of Diagnosing HIV Infection During Early Infancy in South Africa: Test Timing and Frequency
Francke, J. A., Penazzato, M., Hou, T., Abrams, E. J., MacLean, R. L., Myer, L., Walensky, R. P., Leroy, V., Weinstein, M. C., Parker, R. A., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw379 · Cited by 74
Endoscopy for Gastric Cancer Screening Is Cost Effective for Asian Americans in the United States
Shah, S. C., Canakis, A., Peek, R. M., & Saumoy, M. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.07.031 · Cited by 76
Cost-effectiveness analysis of typhoid conjugate vaccines in five endemic low- and middle-income settings
Antillón, M., Bilcke, J., Paltiel, A. D., & Pitzer, V. E. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.05.001 · Cited by 74
Rational decision making in medicine: Implications for overuse and underuse
Djulbegović, B., Elqayam, S., & Dale, W. (2017) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.12851 · Cited by 76
Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
Burger, E. A., Campos, N. G., Sy, S., Regan, C., & Kim, J. J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.04.061 · Cited by 72
Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis
† (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00240-0 · Cited by 73
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences
Younossi, Z. M., Birerdinc, A., & Henry, L. L. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.07.005 · Cited by 70
Are financial incentives cost‐effective to support smoking cessation during pregnancy?
Boyd, K., Briggs, A. H., Bauld, L., Sinclair, L., & Tappin, D. M. (2015) · Addiction · doi:10.1111/add.13160 · Cited by 70
A cost benefit analysis of increasing surgical technology in lumbar spine fusion
Passias, P. G., Brown, A., Alas, H., Bortz, C. A., Pierce, K. E., Hassanzadeh, H. R., Labaran, L. A., Puvanesarajah, V., Vasquez-Montes, D., Wang, E., et al. (2020) · The Spine Journal · doi:10.1016/j.spinee.2020.10.012 · Cited by 68
Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and Technologies
Deeb, W., Giordano, J. J., Rossi, P. J., Mogilner, A. Y., Gunduz, A., Judy, J. W., Klassen, B. T., Butson, C. R., van Horne, C. G., Deny, D., et al. (2016) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2016.00038 · Cited by 69
Patient‐Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition
Younossi, Z. M. (2018) · Hepatology · doi:10.1002/hep.30125 · Cited by 67
Cost-effectiveness of exercise therapy in patients with coronary heart disease, chronic heart failure and associated risk factors: A systematic review of economic evaluations of randomized clinical trials
Oldridge, N., & Taylor, R. S. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319881839 · Cited by 68
Cost-effectiveness of Pancreatic Cancer Surveillance in High-Risk Individuals: An Economic Analysis
Corral, J. E., Das, A., Bruno, M. J., & Wallace, M. B. (2019) · Pancreas · doi:10.1097/mpa.0000000000001268 · Cited by 66
Economic Burden of Hepatitis C Infection
Stepanova, M., & Younossi, Z. M. (2017) · Clinics in Liver Disease · doi:10.1016/j.cld.2017.03.012 · Cited by 70
Recommendations for Epstein-Barr virus–based screening for nasopharyngeal cancer in high- and intermediate-risk regions
Lam, W. K., King, A. D., Miller, J. A., Liu, Z., Yu, K. J., Chua, M. L. K., Ma, B. B. Y., Chen, M., Pinsky, B. A., Lou, P., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad012 · Cited by 64
Seasonal malaria chemoprevention in the Sahel subregion of Africa: a cost-effectiveness and cost-savings analysis
Gilmartin, C., Nonvignon, J., Cairns, M. E., Milligan, P. J., Bocoum, F. Y., Winskill, P., Moroso, D., & Collins, D. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30475-7 · Cited by 63
A New Method to Determine the Optimal Willingness to Pay in Cost-Effectiveness Analysis
Phelps, C. E. (2019) · Value in Health · doi:10.1016/j.jval.2019.03.003 · Cited by 63
Cost-Effectiveness of Thrombectomy in Patients With Acute Ischemic Stroke
Achit, H., Soudant, M., Hosseini, K., Bannay, A., Epstein, J., Bracard, S., & Guillemin, F. (2017) · Stroke · doi:10.1161/strokeaha.117.017856 · Cited by 62
Cost-effectiveness thresholds: methods for setting and examples from around the world
Santos, A. S., Guerra, A. A., Godman, B., Morton, A., & Ruas, C. M. (2018) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1443810 · Cited by 63
Economic evaluation of the Melbourne Mobile Stroke Unit
Kim, J., Easton, D., Zhao, H. H., Coote, S., Sookram, G., Smith, K. L., Stephenson, M., Bernard, S. A., Parsons, M. W., Yan, B., et al. (2020) · International Journal of Stroke · doi:10.1177/1747493020929944 · Cited by 61
Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
Debellut, F., Clark, A. D., Pecenka, C. J., Tate, J. E., Baral, R., Sanderson, C. F. B., Parashar, U. D., Kallen, L. E., & Atherly, D. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30439-5 · Cited by 60
Effectiveness of a Brief Self-determination Theory–Based Smoking Cessation Intervention for Smokers at Emergency Departments in Hong Kong
Li, W., Ho, K., Wang, M., Cheung, D., Lam, K., Xia, W., Cheung, K.-Y., Wong, C., Chan, S., & Lam, T.-H. (2019) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2019.5176 · Cited by 56
Cost-Effectiveness and Quality-Adjusted Survival of Watch and Wait After Complete Response to Chemoradiotherapy for Rectal Cancer
Miller, J. A., Wang, H., Chang, D. T., & Pollom, E. L. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa003 · Cited by 58
Meta-analysis of economic evaluation studies: data harmonisation and methodological issues
Bagepally, B. S., Chaikledkaew, U., Chaiyakunapruk, N., Attia, J., & Thakkinstian, A. (2022) · BMC Health Services Research · doi:10.1186/s12913-022-07595-1 · Cited by 57
Cost-Effectiveness Thresholds in Global Health: Taking a Multisectoral Perspective
Remme, M., Martínez-Álvarez, M., & Vassall, A. (2017) · Value in Health · doi:10.1016/j.jval.2016.11.009 · Cited by 57
Rapid evidence review of the comparative effectiveness, harms, and cost-effectiveness of pharmacogenomics-guided antidepressant treatment versus usual care for major depressive disorder
Peterson, K., Dieperink, E., Anderson, J., Boundy, E., Ferguson, L., & Helfand, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4622-9 · Cited by 56
A systematic review of the health economic consequences of quadrivalent influenza vaccination
de Boer, P. T., van Maanen, B. M., Damm, O., Ultsch, B., Dolk, F. C. K., Crépey, P., Pitman, R., Wilschut, J., & Postma, M. J. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2017.1343145 · Cited by 55
The cost-effectiveness of neonatal versus prenatal screening for congenital toxoplasmosis
Binquet, C., Lejeune, C., Seror, V., Peyron, F., Bertaux, A.-C., Scemama, O., Quantin, C., Béjean, S., Stillwaggon, E. M., & Wallon, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0221709 · Cited by 56
When and how often to screen for cervical cancer in three low- and middle-income countries: a cost-effectiveness analysis
Campos, N. G., Tsu, V., Jeronimo, J., Mvundura, M., Lee, K., & Kim, J. J. (2015) · Papillomavirus Research · doi:10.1016/j.pvr.2015.05.003 · Cited by 56
Cost-effectiveness of chimeric antigen receptor T-cell therapy in adults with relapsed or refractory follicular lymphoma
Potnis, K. C., Di, M., Isufi, I., Gowda, L., Seropian, S., Foss, F. M., Forman, H. P., & Huntington, S. F. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022008097 · Cited by 56
Cervical cancer treatment costs and cost-effectiveness analysis of human papillomavirus vaccination in Vietnam: a PRIME modeling study
Minh, H. V., My, N. T. T., & Jit, M. (2017) · BMC Health Services Research · doi:10.1186/s12913-017-2297-x · Cited by 54
Can community health workers manage uncomplicated severe acute malnutrition? A review of operational experiences in delivering severe acute malnutrition treatment through community health platforms
López‐Ejeda, N., Charle‐Cuéllar, P., Vargas, A., & Guerrero, S. (2018) · Maternal and Child Nutrition · doi:10.1111/mcn.12719 · Cited by 54
Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation
Pooran, A., Theron, G., Zijenah, L. S., Chanda, D. M., Clowes, P., Mwenge, L., Mutenherwa, F., Leccese, P. A., Metcalfe, J. Z., Sohn, H., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30164-0 · Cited by 54
Tranexamic acid for treatment of women with post-partum haemorrhage in Nigeria and Pakistan: a cost-effectiveness analysis of data from the WOMAN trial
Li, B., Miners, A. H., Shakur‐Still, H., & Roberts, I. (2018) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30467-9 · Cited by 53
Cost-effectiveness of HPV vaccination in 195 countries: A meta-regression analysis
Rosettie, K. L., Joffe, J., Sparks, G. W., Aravkin, A. Y., Chen, S., Compton, K., Ewald, S. B., Mathew, E. B., Michael, D., Pedroza, P., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0260808 · Cited by 52
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries
Sekulović, L. K., Guo, J., Agarwala, S. S., Hauschild, A., McArthur, G. A., Cinat, G., Wainstein, A. J. A., Caglevic, C., Lorigan, P. C., Gogas, H. J., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.09.013 · Cited by 52
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn’s Disease: A Cost-Effectiveness Analysis in a Simulated Cohort
Negoescu, D. M., Enns, E. A., Swanhorst, B., Baumgartner, B., Campbell, J. P., Osterman, M. T., Papamichael, K., Cheifetz, A. S., & Vaughn, B. P. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz113 · Cited by 52
Effectiveness and cost-effectiveness of home-based postpartum care on neonatal mortality and exclusive breastfeeding practice in low-and-middle-income countries: a systematic review and meta-analysis
Tiruneh, G. T., Bekele, C., & Worku, A. (2019) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-019-2651-6 · Cited by 52
Protocol for a four parallel-arm, single-blind, cluster-randomised trial to assess the effectiveness of three types of dual active ingredient treated nets compared to pyrethroid-only long-lasting insecticidal nets to prevent malaria transmitted by pyrethroid insecticide-resistant vector mosquitoes in Tanzania
Mosha, J. F., Kulkarni, M. A., Messenger, L. A., Rowland, M., Matowo, N. S., Pitt, C., Lukole, E., Taljaard, M., Thickstun, C., Manjurano, A. M., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-046664 · Cited by 48
A review of typhoid fever transmission dynamic models and economic evaluations of vaccination
Watson, C., & Edmunds, W. J. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.013 · Cited by 53
Value of a QALY for France: A New Approach to Propose Acceptable Reference Values
Téhard, B., Detournay, B., Borget, I., Roze, S., & de Pouvourville, G. (2020) · Value in Health · doi:10.1016/j.jval.2020.04.001 · Cited by 49
Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case
Meyer‐Rath, G., van Rensburg, C., Larson, B. A., Jamieson, L., & Rosen, S. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186496 · Cited by 48
Self-citation
Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review
Alsdurf, H., Empringham, B., Miller, C. R., & Zwerling, A. A. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06633-3 · Cited by 50
Primary healthcare in the time of COVID-19: breaking the silos of healthcare provision
Rifkin, S. B., Fort, M. P., Patcharanarumol, W., & Tangcharoensathien, V. (2021) · BMJ Global Health · doi:10.1136/bmjgh-2021-007721 · Cited by 47
Cost–effectiveness of results-based financing, Zambia: a cluster randomized trial
Zeng, W., Shepard, D. S., Nguyen, H., Chansa, C., Das, A., Qamruddin, J. N., & Friedman, J. A. (2018) · Bulletin of the World Health Organization · doi:10.2471/blt.17.207100 · Cited by 51
Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study
Reddy, K. P., Gupta‐Wright, A., Fielding, K., Costantini, S., Zheng, A., Corbett, E. L., Yu, L., van Oosterhout, J. J., Resch, S., Wilson, D., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(18)30436-4 · Cited by 47
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States
Guy, H., Walder, L., & Fisher, M. (2018) · PharmacoEconomics · doi:10.1007/s40273-018-0745-z · Cited by 50
Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma
Rodin, D. L., Caulley, L., Burger, E. A., Kim, J., Johnson‐Obaseki, S., Palma, D. A., Louie, A. V., Hansen, A. R., & O’Sullivan, B. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.11.029 · Cited by 46
Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome
Wang, Y., Yan, B. P. Y., Liew, D., & Lee, V. W. Y. (2017) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.94 · Cited by 46
Echocardiographic Screening for Rheumatic Heart Disease in Indigenous Australian Children: A Cost–Utility Analysis
Roberts, K., Cannon, J. W., Atkinson, D. N., Brown, A. D. H., Maguire, G. P., Reményi, B., Wheaton, G. R., Geelhoed, E. A., & Carapetis, J. R. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004515 · Cited by 46
Toward Improving Accessibility of Point-of-Care Diagnostic Services for Maternal and Child Health in Low- and Middle-Income Countries
Katoba, J., Kuupiel, D., & Mashamba-Thompson, T. P. (2019) · Point of Care The Journal of Near-Patient Testing & Technology · doi:10.1097/poc.0000000000000180 · Cited by 48

Authors: Marseille, E., Larson, B., Kazi, D. S., Kahn, J. G., & Rosen, S.
Affiliations: Health Strategies International, 555 Fifty-ninth Street, Oakland, California, 94609, United States of America (USA).
Boston University (US)
San Francisco General Hospital (US)
University of California, San Francisco (US)
Corresponding author: Marseille, Elliot
ORCID: Marseille, Elliot
Larson, Bruce
Kazi, Dhruv S
Kahn, James G
Rosen, Sydney
Venue: Bulletin of the World Health Organization
Publisher: WHO Press
Published: 2014-12-15
Volume: 93
Issue: 2
Pages: 118-124
ISSN: 0042-9686 (ISSN-L)
DOI: 10.2471/blt.14.138206
PMC: PMC4339959
OpenAlex: W2133104890
Cited by: 851
References: 42
Citations by year: 2026: 45 · 2025: 68 · 2024: 58 · 2023: 69 · 2022: 93 · 2021: 101 · 2020: 100 · 2019: 105 · 2018: 76 · 2017: 78 · 2016: 40 · 2015: 18
FWCI: 112.73
Type: journal article
Language: en
Open access: diamond
doi.org
Licence: cc-by
Locations: Bulletin of the World Health Organization (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Funders: National Institute of Mental Health (P30MH062246)
National Institute on Drug Abuse (R01DA015612)
Topics: Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Global Health Care Issues
Keywords: cost-effectiveness threshold, WHO-CHOICE, disability-adjusted life years, GDP per capita, healthcare resource allocation, public health decision-making, affordability, cost-effectiveness analysis
MeSH terms: Cost-Benefit Analysis, Developing Countries, Female, Health Priorities, Humans, Pregnancy, Syphilis, Global Health, World Health Organization, HIV Infections, Quality-Adjusted Life Years, Benchmarking, Anti-Retroviral Agents, Insecticide-Treated Bednets, Gross Domestic Product

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Thresholds for the cost–effectiveness of interventions: alternative approaches

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks